401 related articles for article (PubMed ID: 31271810)
1. Prepregnancy care in women with type 1 diabetes improves HbA
Perea V; Giménez M; Amor AJ; Bellart J; Conget I; Vinagre I
Diabetes Res Clin Pract; 2019 Aug; 154():75-81. PubMed ID: 31271810
[TBL] [Abstract][Full Text] [Related]
2. Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes.
Umpierrez GE; O'Neal D; DiGenio A; Goldenberg R; Hernandez-Triana E; Lin J; Park CY; Renard E; Kovatchev B
Diabetes Obes Metab; 2017 Sep; 19(9):1317-1321. PubMed ID: 28256054
[TBL] [Abstract][Full Text] [Related]
3. Effect of Education on Impaired Hypoglycemia Awareness and Glycemic Variability in Children and Adolescents with Type 1 Diabetes Mellitus.
Demir G; Özen S; Çetin H; Darcan Ş; Gökşen D
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):189-195. PubMed ID: 30701953
[TBL] [Abstract][Full Text] [Related]
4. How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?
Inzucchi SE; Umpierrez G; DiGenio A; Zhou R; Kovatchev B
Diabetes Res Clin Pract; 2015 Apr; 108(1):179-86. PubMed ID: 25661664
[TBL] [Abstract][Full Text] [Related]
5. Insulin during pregnancy, labour and delivery.
de Valk HW; Visser GH
Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
[TBL] [Abstract][Full Text] [Related]
6. Basal Insulin Reduces Glucose Variability and Hypoglycaemia Compared to Premixed Insulin in Type 2 Diabetes Patients: A Study Based on Continuous Glucose Monitoring Systems.
Wang H; Zhou Y; Wang Y; Cai T; Hu Y; Jing T; Ding B; Su X; Li H; Ma J
Front Endocrinol (Lausanne); 2022; 13():791439. PubMed ID: 35574003
[TBL] [Abstract][Full Text] [Related]
7. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
Crenier L
Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
[TBL] [Abstract][Full Text] [Related]
8. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
[TBL] [Abstract][Full Text] [Related]
9. Impact of telemedicine assessment on glycemic variability in children with type 1 diabetes mellitus.
Peña NV; Torres M; Cardona JA; Iniesta R
Diabetes Technol Ther; 2013 Feb; 15(2):136-42. PubMed ID: 23289433
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy.
Wen W; Frampton R; Wright K; Fattore S; Shadbolt B; Perampalam S
Diabet Med; 2016 Feb; 33(2):231-4. PubMed ID: 26484625
[TBL] [Abstract][Full Text] [Related]
11. How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?
Inzucchi SE; Umpierrez G; DiGenio A; Zhou R; Kovatchev B
Diabetes Res Clin Pract; 2015 Nov; 110(2):234-40. PubMed ID: 27049155
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
13. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.
Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P
Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236
[TBL] [Abstract][Full Text] [Related]
14. Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.
Manski-Nankervis J; Yates CJ; Blackberry I; Furler J; Ginnivan L; Cohen N; Jenkins A; Vasanthakumar S; Gorelik A; Young D; Best J; O'Neal D
Diabet Med; 2016 Jun; 33(6):803-11. PubMed ID: 26435033
[TBL] [Abstract][Full Text] [Related]
15. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
[TBL] [Abstract][Full Text] [Related]
16. Rationale and protocol for the Assessment of Impact of Real-time Continuous Glucose Monitoring on people presenting with severe Hypoglycaemia (AIR-CGM) study.
Avari P; Ramli R; Reddy M; Oliver N; Fothergill R
BMC Endocr Disord; 2019 Oct; 19(1):110. PubMed ID: 31655586
[TBL] [Abstract][Full Text] [Related]
17. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
[TBL] [Abstract][Full Text] [Related]
18. How can we monitor glycaemic variability in the clinical setting?
Inchiostro S; Candido R; Cavalot F
Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():13-6. PubMed ID: 24034515
[TBL] [Abstract][Full Text] [Related]
19. Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM).
Heller SR; Pratley RE; Sinclair A; Festa A; Kiljański J; Brusko CS; Duan R; Heine RJ
Diabetes Obes Metab; 2018 Jan; 20(1):148-156. PubMed ID: 28671753
[TBL] [Abstract][Full Text] [Related]
20. High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
Farrell CM; McNeilly AD; Hapca S; Fournier PA; Jones TW; Facchinetti A; Cappon G; West DJ; McCrimmon RJ
Diabetologia; 2024 Feb; 67(2):392-402. PubMed ID: 38010533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
